Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-11FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Feasibility of Using a Smart Phone Application for Self-titration of Insulin on Glycemic Control in Patients With T2DM [NA]
This clinical trial update assesses the feasibility of a smartphone application to guide self-titration of insulin in adults with Type 2 dia…
-
CLINICAL_TRIALS withdrawal · 2016-01-11Clinical Trial Update: Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating albiglutide added to basal-bolus insulin therapy in Type 2 diabetes mellitus was withdrawn from the study.
-
FDA approval · 2016-01-08FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) submitted by Novo Nordisk. The action represents regulatory approv…
-
FDA approval · 2016-01-08FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function [EARLY_Phase 1]
An early-phase Phase 1 study completed to evaluate whether purified anthocyanins supplementation affects HDL function in individuals with Ty…
-
FDA label_change · 2016-01-06FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Farxiga (dapagliflozin), resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise [Phase 3]
Phase 3 study evaluating the effectiveness, safety, and tolerability of canagliflozin in combination with metformin in adults with type 2 di…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM) [Phase 4]
Phase 4 clinical trial evaluating 90-day oral testosterone therapy in Chinese men with type 2 diabetes mellitus was terminated; the study mo…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus [Phase 2]
This ClinicalTrials.gov update shows that the Phase 2 study of beloranib in obese subjects with Type 2 diabetes mellitus has been terminated…
-
FDA approval · 2016-01-05FDA Approved: GLYBURIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for glyburide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. for an existing gly…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD [Phase 2]
A Phase 2 trial assessed whether dietary nitrate supplementation can augment the benefits of exercise training in people with peripheral art…
-
FDA approval · 2016-01-05FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for GLIPIZIDE from Actavis Pharma, Inc., enabling continued marketing of the generic drug.
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Glycemic Responses and of the Autonomic Cardiac Function in Diabetes Type-2 Women Post Resistance Exercise [NA]
A completed clinical trial evaluating the effects of resistance exercise on glycemic responses and autonomic cardiac function in women with …
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Clinical and Microbiological Evaluation of Periodontal Treatment of Diabetic Patients: A Longitudinal Study [Phase 2]
A Phase 2 clinical trial update evaluating the clinical and microbiological effects of periodontal treatment in patients with type 2 diabete…
-
CLINICAL_TRIALS withdrawal · 2015-12-30Clinical Trial Update: Sitagliptin in Prevention of Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating sitagliptin for the prevention of Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing NN1250 with insulin glargine in adults with Type 2 diabetes; the study is completed and results were posted in Decem…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Diabetes, Lipoproteins and Accelerated Vascular Disease
A completed clinical study from Columbia University examining how diabetes and lipoproteins influence accelerated vascular disease. The stud…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004) [Phase 1]
A Phase 1 clinical trial evaluating the DPP-4 inhibitor omarigliptin (MK-3102) in obese participants and in participants with Type 2 Diabete…
-
FDA approval · 2015-12-23FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET, the fixed-dose combination of canagliflozin and metformin hydrochloride, submitte…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing liraglutide to lixisenatide as add-on therapy to metformin in adults with type 2 diabetes, reporting efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes [Phase 4]
A Phase 4 trial in Chinese adults with Type 2 diabetes comparing liraglutide plus metformin to sitagliptin plus metformin to evaluate relati…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation [NA]
This completed pilot trial evaluated the effect of purple rice on glucose tolerance, serum lipids, and inflammation in people with type 2 di…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM [Phase 4]
A Phase 4 clinical trial evaluates whether pioglitazone can reverse defects in mitochondrial biogenesis in patients with Type 2 diabetes mel…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing dulaglutide with glimepiride in type 2 diabetes mellitus completed with posted results.